IntraLase & Escalon on better terms

Article

IntraLase has entered into an agreement with Escalon Medical to settle all outstanding disputes and litigation between the parties.

IntraLase has entered into an agreement with Escalon Medical to settle all outstanding disputes and litigation between the parties.

Under the terms of the agreement, IntraLase will make a payment of $9.6 million to Escalon, in exchange for all pending litigations to be dropped. Full ownership of all patents and intellectual property formerly licensed from Escalon will be obtained by IntraLase and all IntraLase obligations under the parties' license agreement will terminate. The payment will also cover all outstanding royalties owed or alleged to be owed by IntraLase to Escalon.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.